83 related articles for article (PubMed ID: 15338719)
1. [Immunomorphological characteristics of the infiltrative growth in well differentiated thyroid carcinoma].
Chipysheva TA; Bronshteĭn MI; Ermilova VD; Gel'shteĭn VI
Arkh Patol; 2002; 64(3):20-5. PubMed ID: 15338719
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of vascular density in proliferative lesions of the thyroid gland].
Szot W; Zaczek M; Nowak K; Dabroś E; Gil K
Folia Med Cracov; 2000; 41(3-4):153-63. PubMed ID: 11339010
[TBL] [Abstract][Full Text] [Related]
3. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
Johnson TL; Lloyd RV; Thor A
Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical characterization of thyroid gland angiomatoid tumors.
Cutlan RT; Greer JE; Wong FS; Eltorky M
Exp Mol Pathol; 2000 Oct; 69(2):159-64. PubMed ID: 11001864
[TBL] [Abstract][Full Text] [Related]
5. Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications.
Rorive S; Eddafali B; Fernandez S; Decaestecker C; André S; Kaltner H; Kuwabara I; Liu FT; Gabius HJ; Kiss R; Salmon I
Mod Pathol; 2002 Dec; 15(12):1294-301. PubMed ID: 12481010
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of extracellular matrix components in native and cultured normal human thyroid tissue and in human toxic adenoma tissue.
Bürgi-Saville ME; Gerber H; Peter HJ; Paulsson M; Aeschlimann D; Glaser C; Kaempf J; Ruchti C; Sidiropoulos I; Bürgi U
Thyroid; 1997 Jun; 7(3):347-56. PubMed ID: 9226202
[TBL] [Abstract][Full Text] [Related]
7. Differential (Ha-, K- and N-) ras p21 expression in benign and malignant human thyroid tumors: an immunohistochemical study.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Hashimoto T
Anticancer Res; 1995; 15(3):755-9. PubMed ID: 7645954
[TBL] [Abstract][Full Text] [Related]
8. Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules.
Trovato M; Villari D; Bartolone L; Spinella S; Simone A; Violi MA; Trimarchi F; Batolo D; Benvenga S
Thyroid; 1998 Feb; 8(2):125-31. PubMed ID: 9510120
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein e expression in anaplastic thyroid carcinoma.
Ito Y; Takano T; Miyauchi A
Oncology; 2006; 71(5-6):388-93. PubMed ID: 17690558
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.
Xu XC; el-Naggar AK; Lotan R
Am J Pathol; 1995 Sep; 147(3):815-22. PubMed ID: 7677193
[TBL] [Abstract][Full Text] [Related]
11. [Enzymohistochemical and immunomorphological study of experimental thyroid gland carcinoma].
Kolodin VI; Okulov VB; Savel'eva OP
Arkh Patol; 1976; 38(12):25-32. PubMed ID: 1016086
[TBL] [Abstract][Full Text] [Related]
12. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
[TBL] [Abstract][Full Text] [Related]
13. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
14. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
Aron M; Kapila K; Verma K
Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
[TBL] [Abstract][Full Text] [Related]
15. Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas.
van Niekerk CC; Boerman OC; Ramaekers FC; Poels LG
Am J Pathol; 1991 Feb; 138(2):455-63. PubMed ID: 1992770
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and progesterone receptors in neoplastic and non-neoplastic thyroid lesions.
Lewy-Trenda I
Pol J Pathol; 2002; 53(2):67-72. PubMed ID: 12140869
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma.
Ito Y; Yoshida H; Nakano K; Kobayashi K; Yokozawa T; Hirai K; Matsuzuka F; Matsuura N; Kuma K; Miyauchi A
Oncology; 2003; 64(1):83-9. PubMed ID: 12457035
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of interleukin 6 in undifferentiated thyroid carcinoma: in vitro and in vivo studies.
Basolo F; Fiore L; Pollina L; Fontanini G; Conaldi PG; Toniolo A
Clin Cancer Res; 1998 Feb; 4(2):381-7. PubMed ID: 9516926
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of thyroid transcription factor-1, thyroglobulin, and calcitonin in canine normal, hyperplastic, and neoplastic thyroid gland.
Ramos-Vara JA; Miller MA; Johnson GC; Pace LW
Vet Pathol; 2002 Jul; 39(4):480-7. PubMed ID: 12126151
[TBL] [Abstract][Full Text] [Related]
20. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
